InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| Zeocin® | Bacteriophage trigger antiviral immunity and prevent clearance of bacterial i... | 2019 | Science | Sweere J.M. et al. | DOI: 10.1126/science.aat9691 |
| HEK-Blue™ Detection | Bacteriophage trigger antiviral immunity and prevent clearance of bacterial i... | 2019 | Science | Sweere J.M. et al. | DOI: 10.1126/science.aat9691 |
| Human TLR3 Reporter HEK293 Cells (NF-κB) | Bacteriophage trigger antiviral immunity and prevent clearance of bacterial i... | 2019 | Science | Sweere J.M. et al. | DOI: 10.1126/science.aat9691 |
| Pam2CSK4 | Specialized dendritic cells induce tumor-promoting IL-10+IL-17+ FoxP3neg regu... | 2019 | Nat Commun. | Barilla R.M. et al. | DOI: 10.1038/s41467-019-09416-2 |
| OVA peptides | Specialized dendritic cells induce tumor-promoting IL-10+IL-17+ FoxP3neg regu... | 2019 | Nat Commun. | Barilla R.M. et al. | DOI: 10.1038/s41467-019-09416-2 |
| Zymosan Depleted | Specialized dendritic cells induce tumor-promoting IL-10+IL-17+ FoxP3neg regu... | 2019 | Nat Commun. | Barilla R.M. et al. | DOI: 10.1038/s41467-019-09416-2 |
| pFUSE-hIgG1-Fc | Improvement in affinity and thermostability of a fully human antibody agains... | 2019 | APSB | Sun W. et al. | DOI: 10.1016/j.apsb.2019.02.007 |
| pFUSE2-CLIg-hK | Improvement in affinity and thermostability of a fully human antibody agains... | 2019 | APSB | Sun W. et al. | DOI: 10.1016/j.apsb.2019.02.007 |
| pFUSE2-CLIg-hL2 | Improvement in affinity and thermostability of a fully human antibody agains... | 2019 | APSB | Sun W. et al. | DOI: 10.1016/j.apsb.2019.02.007 |
| Poly(I:C) LMW | Formulation of aluminum hydroxide adjuvant with TLR agonists poly(I:C) and Cp... | 2019 | Vaccine | Lu F. et al. | DOI: 10.1016/j.vaccine.2019.02.033 |
| ODN 1826 VacciGrade™ | Formulation of aluminum hydroxide adjuvant with TLR agonists poly(I:C) and Cp... | 2019 | Vaccine | Lu F. et al. | DOI: 10.1016/j.vaccine.2019.02.033 |
| EndoFit™ OVA protein | Formulation of aluminum hydroxide adjuvant with TLR agonists poly(I:C) and Cp... | 2019 | Vaccine | Lu F. et al. | DOI: 10.1016/j.vaccine.2019.02.033 |
| OVA protein | Formulation of aluminum hydroxide adjuvant with TLR agonists poly(I:C) and Cp... | 2019 | Vaccine | Lu F. et al. | DOI: 10.1016/j.vaccine.2019.02.033 |
| Plasmocure™ - Mycoplasma Elimination Reagent | Confounding off-target effects of BH3 mimetics at commonly used concentration... | 2019 | Cell Death Dis. | Mallick D.J. et al. | DOI: 10.1038/s41419-019-1426-3 |
| Plasmocure™ - Mycoplasma Elimination Reagent | Identification of rigosertib for the treatment of recessive dystrophic epider... | 2019 | Clin Cancer Res. | Atanasova V.S. et al. | DOI: 10.1158/1078-0432.CCR-18-2661 |
| Plasmocure™ - Mycoplasma Elimination Reagent | Venetoclax Is Effective in Small-Cell Lung Cancers with High BCL-2 Expression. | 2017 | Clin Cancer Res. | Lochmann T.L. et al. | DOI: 10.1158/1078-0432.CCR-17-1606 |
| Poly(I:C) LMW | Energetic Trade-Offs and Hypometabolic States Promote Disease Tolerance. | 2019 | Cell | Ganeshan K. et al. | DOI: 10.1016/j.cell.2019.01.050 |
| Imiquimod (R837) | Energetic Trade-Offs and Hypometabolic States Promote Disease Tolerance. | 2019 | Cell | Ganeshan K. et al. | DOI: 10.1016/j.cell.2019.01.050 |
| Pam3CSK4 | Energetic Trade-Offs and Hypometabolic States Promote Disease Tolerance. | 2019 | Cell | Ganeshan K. et al. | DOI: 10.1016/j.cell.2019.01.050 |
| ODN 1826 - TLR9 ligand | Energetic Trade-Offs and Hypometabolic States Promote Disease Tolerance. | 2019 | Cell | Ganeshan K. et al. | DOI: 10.1016/j.cell.2019.01.050 |